Skip to content
Browse

Edition

Sections

Appearance

AboutSourcesContactPrivacy

Pharma sector earnings rise 5pc despite weak sales growth in 3QCY26

KARACHI: Pakistan’s listed pharmaceutical companies recorded a 5 percent year-on-year increase in cumulative earnings during the third quarter of calendar year 2026, despite a 1 percent decline in revenue, as improved gross margins and cost optimisation supported profitability amid export disruptions and higher trade discounts. A sample of nine listed pharmaceutical companies, representing…

First reported by Business Recorder 1 source
Image: Business Recorder
Image: Business Recorder
Read at Business Recorder(opens in a new tab)

Full coverage

Every report we found on this story, oldest first. Each links to the original publisher.

  1. Business Recorder

    Pharma sector earnings rise 5pc despite weak sales growth in 3QCY26 (opens Business Recorder in a new tab)

    KARACHI: Pakistan’s listed pharmaceutical companies recorded a 5 percent year-on-year increase in cumulative earnings during the third quarter of calendar year 2026, despite a 1 percent decline in revenue, as improved gross margins and cost optimisation…

Something wrong with how we've grouped or summarised this story? Report a problem